Colgate-Palmolive Co. [CL] stock prices are up 0.50% to $89.20 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CL shares have gain 2.32% over the last week, with a monthly amount glided 6.75%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 12, March 2024, ZO® Skin Health Appoints Industry Veteran Justin Skala as CEO to Continue Strong Growth. In a post published today on Yahoo Finance, ZO® Skin Health, a premium clinical dermatological skincare brand distributed globally through physicians and skincare professionals, today announced the appointment of Justin Skala as Chief Executive Officer. Mr. Skala brings more than 35 years of leadership experience growing high efficacy products through the professional channel, including driving the expansion of the personal care category over his tenure at Colgate-Palmolive, Inc. (NYSE: CL). He succeeds Mark Williams who will continue to serve the company on its Board of Directors.
From an analyst’s perspective:
Previously, Raymond James upgraded its rating to Outperform on January 29, 2024. On December 15, 2023, upgrade upgraded it’s rating to Buy but maintained its price target of $90 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $87 on November 13, 2023. Stifel upgraded its rating to a Buy and reduced its price target to $81 on October 16, 2023. HSBC Securities started tracking with a Buy rating for this stock on September 22, 2023, and assigned it a price target of $84. In a note dated February 17, 2023, Citigroup initiated an Buy rating and provided a target price of $84 on this stock.
The stock price of Colgate-Palmolive Co. [CL] has been fluctuating between $67.62 and $89.19 over the past year. Currently, Wall Street analysts expect the stock to reach $85.71 within the next 12 months. Colgate-Palmolive Co. [NYSE: CL] shares were valued at $89.20 at the most recent close of the market. An investor can expect a potential drop of -3.91% based on the average CL price forecast.
Analyzing the CL fundamentals
The Colgate-Palmolive Co. [NYSE:CL] reported sales of 19.46B for trailing twelve months, representing a surge of 6.93%. Gross Profit Margin for this corporation currently stands at 0.58% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.12%. To continue investigating profitability, this company’s Return on Assets is posted at 0.14, Equity is 17.36 and Total Capital is 0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of14.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 88.70 points at the first support level, and at 88.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 89.53, and for the 2nd resistance point, it is at 89.86.
Colgate-Palmolive Co. [CL] reported earnings per share of $0.87 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.85/share, meaning a difference of $0.02 and a surprise factor of 2.40%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.86 per share as compared to estimates of $0.8 per share, a difference of $0.06 representing a surprise of 7.50%.
Ratios To Look Out For
It’s worth pointing out that Colgate-Palmolive Co. [NYSE:CL]’s Current Ratio is 1.11. Also, the Quick Ratio is 0.71, while the Cash Ratio stands at 0.2. Considering the valuation of this stock, the price to sales ratio is 3.77, the price to book ratio is 120.31 and price to earnings (TTM) ratio is 32.13.
Transactions by insiders
Recent insider trading involved Wallace Noel R., Chairman, President & CEO, that happened on Feb 20 ’24 when 69948.0 shares were sold. CLO and Secretary, Daniels Jennifer completed a deal on Feb 20 ’24 to sell 3538.0 shares. Meanwhile, Grp Pres, Growth & Strategy Parameswaran Prabha sold 56836.0 shares on Feb 16 ’24.
